VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,828,202 | -71.2% | 288,703 | -59.2% | 0.00% | -66.7% |
| Q2 2023 | $13,275,750 | +111.8% | 708,040 | +62.9% | 0.00% | +200.0% |
| Q1 2023 | $6,267,826 | +105.5% | 434,662 | +175.7% | 0.00% | 0.0% |
| Q4 2022 | $3,050,218 | -62.2% | 157,634 | -32.8% | 0.00% | -50.0% |
| Q3 2022 | $8,063,000 | -57.1% | 234,730 | -80.9% | 0.00% | -60.0% |
| Q2 2022 | $18,802,000 | -18.5% | 1,230,555 | +21.7% | 0.01% | 0.0% |
| Q1 2022 | $23,078,000 | +9.9% | 1,011,330 | +77.6% | 0.01% | +25.0% |
| Q4 2021 | $20,995,000 | -31.2% | 569,410 | -14.6% | 0.00% | -33.3% |
| Q3 2021 | $30,508,000 | -37.4% | 666,384 | -19.7% | 0.01% | -45.5% |
| Q2 2021 | $48,701,000 | – | 829,589 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |